# Clinical Utility and Safety of Human Umbilical Cord Mesenchymal Stem Cell Secretome in Drug Resistant Epilepsy Single Center, Non-randomized, Phase I Clinical Trial

> **NCT06638970** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Baermed** · enrollment: 54 (estimated)

## Conditions studied

- Epilepsy
- Drugs Resistant Epilepsy

## Interventions

- **DRUG:** Secretome

## Key facts

- **NCT ID:** NCT06638970
- **Lead sponsor:** Baermed
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2025-10-31
- **Final completion:** 2026-10-31
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2024-10-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06638970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06638970, "Clinical Utility and Safety of Human Umbilical Cord Mesenchymal Stem Cell Secretome in Drug Resistant Epilepsy Single Center, Non-randomized, Phase I Clinical Trial". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06638970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*